Development of ATP-competitive mTOR Inhibitors

Documenti analoghi

• Discovery of 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo[h][1,6]naphthyridin-2(1H)-one as a highly potent, selective Mammalian Target of Rapamycin (mTOR) inhibitor for the treatment of cancer
  di: Liu, Qingsong, et al.
  Pubblicazione: (2010)
• Discovery and optimization of potent and selective benzonaphthyridinone analogs as small molecule mTOR inhibitors with improved mouse microsome stability
  di: Liu, Qingsong, et al.
  Pubblicazione: (2011)
• mTOR Mediated Anti-Cancer Drug Discovery
  di: Liu, Qingsong, et al.
  Pubblicazione: (2009)
• An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1
  di: Thoreen, Carson C., et al.
  Pubblicazione: (2009)
• Correction: An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1.
  di: Thoreen, Carson C., et al.
  Pubblicazione: (2020)